Ireland
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
31.98%
|
Dec. 31, 2023 | USD 124.37 | -0.54% |
|
Ireland |
|
2 |
31.23%
|
Dec. 31, 2023 | USD 31.53 | -1.19% |
|
Ireland |
|
3 |
27.85%
|
Oct. 25, 2024 | USD 90.82 | -0.95% |
|
Ireland |
|
4 |
22.73%
|
Dec. 31, 2024 | USD 225.44 | 2.09% |
|
Ireland |
|
5 |
21.23%
|
Dec. 31, 2023 | USD 70.72 | 0.21% |
|
Ireland |
|
6 |
18.74%
|
Dec. 31, 2023 | USD 199.08 | -1.31% |
|
Ireland |
|
7 |
4.32%
|
Dec. 31, 2023 | USD 2.56 | 3.17% |
|
Ireland |
|
8 |
-208.06%
|
Dec. 31, 2023 | USD 14.23 | -3.20% |
|
Ireland |
|
9 |
-533.29%
|
Dec. 31, 2023 | USD 7.90 | 2.73% |
|
Ireland |
The Healthcare company in Ireland with the highest EBITDA Margin is Jazz Pharmaceuticals plc (NasdaqGS: JAZZ) at 31.98%.
The Healthcare company in Ireland with the lowest EBITDA Margin is Avadel Pharmaceuticals plc (NasdaqGM: AVDL) at -533.29%.
The top 10 Healthcare companies in Ireland by EBITDA Margin are Jazz Pharmaceuticals plc, Alkermes plc, Medtronic plc, STERIS plc, Cosmo Pharmaceuticals N.V., ICON Public Limited Company, Uniphar plc, Prothena Corporation plc and Avadel Pharmaceuticals plc.
The bottom 10 Healthcare companies in Ireland by EBITDA Margin are Avadel Pharmaceuticals plc, Prothena Corporation plc, Uniphar plc, ICON Public Limited Company, Cosmo Pharmaceuticals N.V., STERIS plc, Medtronic plc, Alkermes plc and Jazz Pharmaceuticals plc.